{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T11:49:13Z","timestamp":1789386553113,"version":"build-2803163510"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2014,8,19]],"date-time":"2014-08-19T00:00:00Z","timestamp":1408406400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neural Transm"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1007\/s00702-014-1297-9","type":"journal-article","created":{"date-parts":[[2014,8,18]],"date-time":"2014-08-18T19:26:35Z","timestamp":1408389995000},"page":"835-839","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Treatment of camptocormia with continuous subcutaneous infusions of apomorphine: 1-year prospective pilot study"],"prefix":"10.1007","volume":"122","author":[{"given":"Katerina","family":"Mensikova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michaela","family":"Kaiserova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miroslav","family":"Vastik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Kurcova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petr","family":"Kanovsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,8,19]]},"reference":[{"key":"1297_CR1","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1002\/mds.21058","volume":"21","author":"R Ashour","year":"2006","unstructured":"Ashour R, Jankovic J (2006) Joint and skeletal deformities in Parkinson\u2019s disease, multiple system atrophy, and progressive supranuclear palsy. Mov Disord 21:1856\u20131863","journal-title":"Mov Disord"},{"key":"1297_CR2","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1468-1331.2010.03049.x","volume":"17","author":"F Asmus","year":"2010","unstructured":"Asmus F, Gasser T (2010) Dystonia-plus syndromes. Eur J Neurol 17:37\u201345","journal-title":"Eur J Neurol"},{"key":"1297_CR3","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1136\/jnnp.2006.087908","volume":"77","author":"F Bloch","year":"2006","unstructured":"Bloch F, Houeto JL, Tezenas du Montel S, Bonnevile F, Etchepare F, Welter ML (2006) Parkinson\u2019s disease with camptocormia. J Neurol Neurosurg Psychiatry 77:1223\u20131228","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1297_CR4","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1002\/mds.21694","volume":"22","author":"L Bonnani","year":"2007","unstructured":"Bonnani L, Thomas A, Varanese S, Scorrano V, Onofrj M (2007) Botulinum toxin treatment of lateral axial dystonia in parkinsonism. Mov Disord 22:2097\u20132103","journal-title":"Mov Disord"},{"key":"1297_CR5","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.annrmp.2006.07.060","volume":"50","author":"E Bouzgarou","year":"2007","unstructured":"Bouzgarou E, Dupeyron A, Castelnovo G, Boudousq V, Collombier L, Labauge P, Pelisier J (2007) Camptocormia disclosing Parkinson\u2019s disease. Ann Readapt Med Phys 50:55\u201359","journal-title":"Ann Readapt Med Phys"},{"key":"1297_CR6","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1002\/mds.21484","volume":"22","author":"E Brousolle","year":"2007","unstructured":"Brousolle E, Krack P, Thobois S, Xie-Brustolin J, Pollak P (2007) Contribution of Jules Froment to the study of parkinsonian rigidity. Mov Disord 22:909\u2013914","journal-title":"Mov Disord"},{"key":"1297_CR7","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1136\/jnnp.64.5.573","volume":"64","author":"A Colzi","year":"1998","unstructured":"Colzi A, Turner K, Lees A (1998) Continuous subcutaneous waking day apomorphine in the long term treatment of levodopa induced interdose dyskinesias in Parkinson\u2019s disease. J Neurol Neurosurg Psychiatry 64:573\u2013576","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1297_CR8","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1002\/1531-8257(199905)14:3<443::AID-MDS1009>3.0.CO;2-G","volume":"14","author":"R Djaldetti","year":"1999","unstructured":"Djaldetti R, Mosberg-Galili R, Sroka H, Merims D, Melamed E (1999) Camptocormia (bent spine) in patients with Parkinson\u2019s disease\u2014characterization and possible pathogenesis of an unusual phenomenon. Mov Disord 14:443\u2013447","journal-title":"Mov Disord"},{"key":"1297_CR9","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.parkreldis.2012.09.008","volume":"19","author":"Y Furusawa","year":"2013","unstructured":"Furusawa Y, Mukai Y, Kawazoe T, Sano T, Nakamura H, Sakamoto C, Iwata Y, Wakita M, Nakata Y, Kamiya K, Kobayashi Y, Sakamoto T, Takiyama Y, Murata M (2013) Long-term effect of repeated lidocaine injections into the external oblique for upper camptocormia in Parkinson\u2019s disease. Parkinsonism Relat Disord 19:350\u2013354","journal-title":"Parkinsonism Relat Disord"},{"key":"1297_CR10","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/mds.22909","volume":"25","author":"BK Gerton","year":"2010","unstructured":"Gerton BK, Theeler B, Samii A (2010) Backpack treatment for camptocormia. Mov Disord 25:247\u2013248","journal-title":"Mov Disord"},{"key":"1297_CR11","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1254\/jphs.09R28FM","volume":"114","author":"H Ichinose","year":"2010","unstructured":"Ichinose H, Ikemoto K, Nomura T, Kondo K (2010) Advanced research on dopamine signaling to develop drugs for the treatment of mental disorders: regulation of dopaminergic neural transmission by tyrosine hydroxylase protein at nerve terminals. J Pharmacol Sci 114:17\u201324","journal-title":"J Pharmacol Sci"},{"key":"1297_CR12","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1002\/mds.1276","volume":"17","author":"P Kanovsky","year":"2002","unstructured":"Kanovsky P, Kubova D, Bares M, Hortova H, Streitova H, Rektor I, Znojil V (2002) Levodopa-induced dyskinesias and continuous subcutaneous infusions of apomorphine: results of a two-year, prospective follow-up. Mov Disord 17:188\u2013191","journal-title":"Mov Disord"},{"key":"1297_CR13","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1002\/mds.20276","volume":"20","author":"R Katzenschlager","year":"2005","unstructured":"Katzenschlager R, Hughes A, Evans A, Manson A, Hoffman M, Swinn L, Watt H, Bhatia K, Quinn N, Lees A (2005) Continuous subcutaneous apomorphine therapy improves dyskinesias in Parkinson\u2019s disease: a prospective study using single-dose challenges. Mov Disord 20:151\u2013157","journal-title":"Mov Disord"},{"key":"1297_CR14","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1002\/mds.10281","volume":"17","author":"A Manson","year":"2002","unstructured":"Manson A, Turner K, Lees AJ (2002) Apomorphine monotherapy in the treatment of refractory motor complications of Parkinson\u2019s disease: long-term follow-up study of 64 patients. Mov Disord 17:1235\u20131241","journal-title":"Mov Disord"},{"key":"1297_CR15","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1002\/mds.22780","volume":"25","author":"NG Margraf","year":"2010","unstructured":"Margraf NG, Wrede A, Rohr A, Schulz-Schaeffer WJ, Raethjen J, Eymess A, Volkmann J, Mehdorn MH, Jansen O, Deuschl G (2010) Camptocormia in idiopathic Parkinson\u2019s disease: a focal myopathy of the paravertebral muscles. Mov Disord 25:542\u2013551","journal-title":"Mov Disord"},{"key":"1297_CR16","doi-asserted-by":"crossref","unstructured":"Marianna C, Chiara S, Luca F, Giovanna C, Matteo F, Chiara O, Renzi R, Leandro P, Gabriella CM (2014) Postural rehabilitation and Kinesio Taping for axial postural disorders in Parkinson\u2019s disease. Arch Phys Med Rehabil. doi: 10.1016\/j.apmr.2014.01.020","DOI":"10.1016\/j.apmr.2014.01.020"},{"issue":"9","key":"1297_CR17","doi-asserted-by":"crossref","first-page":"73547","DOI":"10.1371\/journal.pone.0073547","volume":"8","author":"T Oeda","year":"2013","unstructured":"Oeda T, Umemura A, Tomita S, Hayashi R, Kohsaka M, Sawada H (2013) Clinical factors associated with abnormal postures in Parkinson\u2019s disease. PLoS ONE 8(9):73547","journal-title":"PLoS ONE"},{"key":"1297_CR18","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/WNF.0000000000000024","volume":"37","author":"S Oravivattanakul","year":"2014","unstructured":"Oravivattanakul S, Abboud H, Fernandez H, Itin I (2014) Unusual case of levodopa-responsive camptocormia in a patient with negative dopamine transporter scan and normal DYT 5 gene. Clin Neuropharmacol 37:63\u201364","journal-title":"Clin Neuropharmacol"},{"key":"1297_CR19","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1136\/jnnp.65.5.709","volume":"65","author":"K Pietz","year":"1998","unstructured":"Pietz K, Hagell P, Odin P (1998) Subcutaneous apomorphine in late stage Parkinson\u2019s disease: a long term follow up. J Neurol Neurosurg Psychiatry 65:709\u2013716","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1297_CR20","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.parkreldis.2013.10.022","volume":"20","author":"R Reese","year":"2014","unstructured":"Reese R, Knudsen K, Falk D, Mehdorn HM, Deuschl G, Volkmann J (2014) Motor outcome of dystonic camptocormia treated with pallidal neurostimulation. Parkinsonism Relat Disord 20:176\u2013179","journal-title":"Parkinsonism Relat Disord"},{"key":"1297_CR21","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.braindev.2010.10.015","volume":"33","author":"M Segawa","year":"2011","unstructured":"Segawa M (2011) Hereditary progressive dystonia with marked diurnal fluctuation. Brain Dev 33:195\u2013201","journal-title":"Brain Dev"},{"key":"1297_CR22","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1007\/s00415-013-6945-8","volume":"260","author":"M Tinazzi","year":"2013","unstructured":"Tinazzi M, Juergenson I, Squintani G, Vattemi G, Montemezzi S, Censi D, Barone P, Bovi T, Fasano A (2013) Pisa syndrome in Parkinson\u2019s disease: an electrophysiological and imaging study. J Neurol 260:2138\u20132148","journal-title":"J Neurol"}],"updated-by":[{"DOI":"10.1007\/s00702-015-1385-5","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2015,3,21]],"date-time":"2015-03-21T00:00:00Z","timestamp":1426896000000}}],"container-title":["Journal of Neural Transmission"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-014-1297-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00702-014-1297-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-014-1297-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T04:30:30Z","timestamp":1559104230000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00702-014-1297-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8,19]]},"references-count":22,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["1297"],"URL":"https:\/\/doi.org\/10.1007\/s00702-014-1297-9","relation":{"correction":[{"id-type":"doi","id":"10.1007\/s00702-015-1385-5","asserted-by":"object"}]},"ISSN":["0300-9564","1435-1463"],"issn-type":[{"value":"0300-9564","type":"print"},{"value":"1435-1463","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,8,19]]}}}